Chronic P38 Mitogen-Activated Protein Kinase Inhibition Improves Vascular Function and Remodeling in Angiotensin II-dependent Hypertension

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System - United Kingdom
doi 10.1177/1470320316653284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

P38 Mitogen-Activated Protein Kinase Inhibition Ameliorates Angiotensin II-Induced Target Organ Damage

Hypertension
Internal Medicine
2007English

Inhibition of P38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2010English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2014English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2012English

Big Mitogen-Activated Protein Kinase: A New Player in Vascular Remodeling

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2007English

Angiotensin II-Induced Hypertension : Contribution of Ras GTPase/Mitogen-Activated Protein Kinase and Cytochrome P450 Metabolites

Hypertension
Internal Medicine
2000English

Catechins Inhibit Angiotensin II-induced Vascular Smooth Muscle Cell Proliferation via Mitogen-Activated Protein Kinase Pathway

Experimental & Molecular Medicine
2006English

P38 Mitogen-Activated Protein Kinase Regulates IL‐8 Expression in Human Pulmonary Vascular Endothelial Cells

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1999English

Mitogen-Activated Protein Kinase Kinase 1/2 Inhibition and Angiotensin II Converting Inhibition in Mice With Cardiomyopathy Caused by Lamin a/C Gene Mutation

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy